Aevitas Wealth Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $1.16M | Buy |
|
|||||
|
2022
Q3 | $946K | Hold |
|
|||||
|
2022
Q2 | $689K | Sell |
|
|||||
|
2022
Q1 | $891K | Hold |
|
|||||
|
2021
Q4 | $925K | Hold |
|
|||||
|
2021
Q3 | $1.03M | Hold |
|
|||||
|
2021
Q2 | $925K | Hold |
|
|||||
|
2021
Q1 | $770K | Buy |
|
|||||
|
2020
Q4 | $704K | Hold |
|
|||||
|
2020
Q3 | $789K | Sell |
|
|||||
|
2020
Q2 | $876K | Sell |
|
|||||
|
2020
Q1 | $722K | Hold |
|
|||||
|
2019
Q4 | $764K | Hold |
|
|||||
|
2019
Q3 | $533K | Sell |
|
|||||
|
2019
Q2 | $493K | Sell |
|
|||||
|
2019
Q1 | $653K | Sell |
|
|||||
|
2018
Q4 | $521K | Sell |
|
|||||
|
2018
Q3 | $634K | Hold |
|
|||||
|
2018
Q2 | $714K | Sell |
|
|||||
|
2018
Q1 | $899K | Sell |
|
|||||
|
2017
Q4 | $997K | Buy |
|